组织因子途径抑制物-1,tissue factor pathway inhibitor-1
1)tissue factor pathway inhibitor-1组织因子途径抑制物-1
1.Dynamic changes of plasma tissue factor and tissue factor pathway inhibitor-1 and their clinical significance in patients with multiple traumas多发伤早期组织因子及组织因子途径抑制物-1的变化及其意义
英文短句/例句

1.Dynamic changes of plasma tissue factor and tissue factor pathway inhibitor-1 and their clinical significance in patients with multiple traumas多发伤早期组织因子及组织因子途径抑制物-1的变化及其意义
2.The Relationship Between Tissue Factor Pathway Inhibitor-2 and Gynecological Tumors组织因子途径抑制物-2与妇科肿瘤
3.Cloning, Expression and Functional Study of Tissue Factor Pathway Inhibitor-2 and Its First Kunitz Domain;组织因子途径抑制物-2及其结构域1的基因克隆、表达和功能研究
4.A Study of Relation between Tissue Factor Pathway and Coronary Heart Disease组织因子及组织因子途径抑制物与冠心病的相关性研究
5.Tissue Factor Pathway Inhibitor Effects Tissue Factor in Early Stage Atherosclerosis组织因子途径抑制物对动脉粥样硬化早期阶段组织因子的影响
6.Studies on Expression of Human Tissue Factor Pathway Inhibitor-2 in Pichia Pastoris;重组人组织因子途径抑制物-2在毕赤酵母中表达的研究
7.Study on Large-scale Fermentation and Purification of Recombinant Human Tissue Factor Pathway Inhibitor 2;重组人组织因子途径抑制物2的大规模发酵及纯化的研究
8.Analysis of Nuclear Factor-Kappa B Activity in the Kidney and Plasma Levels of Tissue Factor and Tissue Factor Pathway Inhibitor in Children with Idiopathic Nephrotic Syndrome;INS患儿肾组织NF-κB活性、血浆组织因子及组织因子途径抑制物的水平研究
9.Experimental Study on Expression of Tissue Factor Pathway Inhibitor-2 in Human Fetal Membrane of PROM;组织因子途径抑制物-2在胎膜早破中表达的实验研究
10.Study of Tissue Factor Pathway Inhibitor-2 during the Invasion and Metastasis of Breast Cancer组织因子途径抑制物-2(hTFPI-2)与乳腺癌侵袭转移的相关性研究
11.The Influence of TFPI-2 on the Growth and the Invasion of K562 Cells组织因子途径抑制物-2对K562细胞生长和侵袭能力的影响
12.The expression of tissue factor pathway inhibitor-2 and invasion capability of hepatocellular carcinoma in vitro组织因子途径抑制物-2表达与肝癌细胞体外侵袭能力的实验研究
13.Polymorphisms of tissue factor pathway inhibitors C-399T in venous thromboembolism静脉血栓栓塞症组织因子途径抑制物C-399T多态性的研究
14.Polymorphisms of tissue factor pathway inhibitors C-399T and T-287C in venous thromboembolism静脉血栓栓塞症组织因子途径抑制物C-399T和T-287C多态性的研究
15.Effects of TNF-α on the expression of TF and TFPI in vascular endothelial cells肿瘤坏死因子-α对内皮细胞组织因子和组织因子途径抑制物表达的影响
16.Regulation Effect of Alph α-Melanocyte Stimulating Hormone and Its Analogue on the Expression of Tissue Factor and Tissue Factor Pathway Inhibitor;α-黑素细胞刺激素及其类似物对组织因子和组织因子途径抑制物的调节作用
17.Effects of Adiponectin on Tissue Factor and Tissue Factor Pathway Inhibitor Expression and Its Mechanisms in Vascular Endothelial Cells;脂联素对内皮细胞组织因子和组织因子途径抑制物表达的影响及机制研究
18.Optimization of Expression Conditions for Purification of Recombinant Tissue Factor Pathway Inhibitors组织因子途径抑制因子重组蛋白表达和纯化方法的优化
相关短句/例句

Tissue Factor Pathway Inhibitor 2组织因子途径抑制物2
3)tissue factor pathway inhibitor-2组织因子途径抑制物-2
1.Tissue factor pathway inhibitor-2(TFPI-2) belongs to the Kunitz-type serine proteinase inhibitor family,and it is a broad-spectrum inhibitor of serine proteinase.组织因子途径抑制物-2(TFPI-2)属于库尼(Kunitz)型丝氨酸蛋白酶抑制剂家族蛋白,是一种广谱的丝氨酸蛋白酶抑制物。
4)tissue factor pathway inhibitor组织因子途径抑制物
1.Value of plasma tissue factor, tissue factor pathway inhibitor and factor Ⅶ assessments in patients with acute myocardial and cerebral infarction;急性心肌梗死及脑梗死患者组织因子、组织因子途径抑制物、因子Ⅶ的检测及临床意义
2.Expressions of tissue factor and tissue factor pathway inhibitor in the atherosclerotic plaque;粥样硬化斑块中组织因子和组织因子途径抑制物的表达
3.Anticoagulation inhibition effects of the monoclonal antibody aginst the recombinant human tissue factor pathway inhibitor 1 on rhTFPI;抗重组人组织因子途径抑制物1单抗抑制rhTFPI-1的抗凝作用
5)Tissue factor pathway inhibitors组织因子途径抑制物类
6)Tissue factor pathway inhibitor-2组织因子途径抑制物2
1.Tissue factor pathway inhibitor-2(TFPI-2) is a matrix-associated Kunitz-type domains serine protinase inhibitor with molecular mass about 32×103.组织因子途径抑制物2(TFPI-2)是相对分子质量为32×103的基质相关的库尼(Kun itz)型丝氨酸蛋白酶抑制剂。
延伸阅读

正常人白细胞转移因子 , 白细胞转移因子,转移因子药物名称:转移因子英文名:Transfer Factor别名: 正常人白细胞转移因子 , 白细胞转移因子,转移因子外文名:Transfer Factor ,TF适应症: 为细胞免疫反应增强剂,能将细胞免疫活性转移给受体,以提高受体的免疫功能。临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染(如带状皰疹、流行性乙型脑炎、白色念珠菌感染等)。对恶性肿瘤可作为辅助治疗剂,对自体免疫性疾病也有一定治疗作用。 用量用法: 一般采用皮下注射,注于上臂内侧或大腿内侧腹股沟下端,1次注射1支,每周1~2次,1个月后改为每2周1次。对带状疱疹,一般只需注射1次。 规格: 注射液:每支2ml,相当于1×1000000000白细胞提取物(上海产),北京产则相当于5~10×1000000000. 注:严禁静脉给药.类别:免疫调节剂